A clinical trial under the UKM-PS-III protocol has been completed. Thanks to all the participants!

A selection visit was successfully completed to participate in a simple, blind, randomized, parallel-group study comparing the efficacy, safety, immunogenicity, and pharmacodynamics of Stelara® iStileukin® drugs at the supportive stage of treatment for moderate to severe ulcerative colitis (UC) with ineffectiveness/loss of clinical response/intolerance to previous treatment, sponsored by GENERIUM JSC.", Russia

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen